Medy-Tox Inc. (KOSDAQ: A086900)
Health Care · Biotechnology · KR
₩67,400.00
-12.35% today · -43.6% 1Y
Medy-Tox Inc. (KOSDAQ: A086900) operates in the Biotechnology industry within the Health Care sector. The company is valued at $316.97M.
Over the last twelve months the share price has lost 43.6%, trading between 66.00K and 141.10K.
Tweenvest scores Medy-Tox Inc. across four factors: quality 66/100, value 73/100, dividend 18/100. Its strongest factor is value.
A086900 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $316.97M
- Revenue (TTM)
- $162.13M
- P/E
- 30.12
- EPS
- 2,237.82
- Dividend yield
- 1.78%
- Beta (5Y)
- 0.42
- 52-week high
- ₩141,100.00
- 52-week low
- ₩66,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.52M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $266.14 | +0.45% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.50 | +0.27% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.69 | +0.39% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.14 | +0.01% |
| argenx SEENXTBR: ARGX | $65.85B | €882.20 | -2.20% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $143.01 | -1.42% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.